SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics (NASDAQ: CYTX) (the “Company”) today announced that the Company and Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services, increased the contract option originally signed in August 2014 to fund continued investigation and development of Cytori Cell Therapy™ for use in thermal burn injuries. The amended option is valued at $16.6 million, an increase of approximately $2.5 milli